Beth McLellan, MD is a board-certified dermatologist and researcher in Montefiore’s Division of Dermatology and with Montefiore Einstein Center for Cancer Care. She is also Director of Dermatology at Jacobi Medical Center. She is committed to improving oncology patients’ quality of life and preventing interruptions in their care.
Prior to joining Montefiore, Dr. McLellan served as a full-time faculty member at New York University where she saw all inpatient dermatology consults and developed an oncodermatology program. Her medical training includes an internship in internal medicine at Loyola Medicine and dermatology residency at Henry Ford Health System in Detroit, where she served as chief resident and initiated a supportive oncodermatology clinic. Dr. McLellan received additional oncodermatology training at Memorial Sloan Kettering Cancer Center and at the Institute Gustave Roussy in Paris. She has received awards from the Women’s Dermatology Society and the Dermatology Foundation. She regularly lectures at both dermatology and oncology meetings and is actively involved in teaching medical students and residents.
Dr. McLellan specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies. Dr. McLellan has received a Career Development Award from the Dermatology Foundation to study hair loss in breast cancer patients on hormonal treatments. In addition to hair loss, her research interests include hand foot syndrome and radiation dermatitis.
Dr. McLellan has published numerous articles and textbook chapters related to supportive oncodermatology. She is regularly invited to speak at dermatology and oncology conferences including, the annual meeting of the American Academy of Dermatology, the South Beach Symposium and the International Symposium for Supportive Care in Cancer.
Cases In Oncodermatology
This lecture will review some common reactions to cancer therapies, as well as dermatologic problems in cancer survivors in case-based approach. Reactions covered will include: hand foot skin reactions, papulopustular eruption, onycholysis, cutaneous metastases, nummular dermatitis of the reconstructed breast and secondary skin cancers following radiation therapy.
- Review how to recognize and manage common side effects from traditional and targeted chemotherapeutic agents, including hand foot skin reaction, papulopustular eruption and onycholysis
- Help attendees improve communication with oncologists by using common terminology and grading systems for treatment-related toxicities
- Review the importance of dermatologic care in cancer survivors, especially surveillance for secondary skin cancers
- Advances in medical knowledge
- Chaput B, Filleron T, Le Guellec S, Meresse T, Courtade-Saidi M, Grolleau JL, Chevreau C, Garrido I, Gangloff D. Histological Techniques in Oncodermatology. Annales de Chirurgie Plastique et Esthetique. 2012;57(2):132-139.
- Servy A, Kramkinel N, Franck N, Park S, Kirova YM. Helical Tomotherapy in Oncodermatology: Case Report of Circumferential Cutaneous Lymphoma Treated by this Optimized Radiotherapy. Cancer Radiother. 2014 Mar;18(2):136-8. Doi:10.1016/j.canrad.2013.10.011. Epub 2014 Jan 10.
- Maksimova N, Przhedetsky Y, Pozdnyakova V, Ilchenko M, Kuryshova M, Khokhlova O, Zakharova N, Rostov Scientific Research Institute of Oncology, Rostov-on-Don, Russia. Potential of Ultrasound Scanning in Oncodermatology. J Clin Oncol. 33, 2015.
Core Competencies: 2, 3, 4, 7
Disclosures: Stockholder of Spruce Health; Advisor for Spruce Health; Consultant for Biopelle